Merchavia Holdings and Investments Ltd (TLV:MRHL)
125.30
-8.00 (-6.00%)
Sep 23, 2026, 5:24 PM IDT
TLV:MRHL Revenue
Merchavia Holdings and Investments had revenue of 62.00K ILS in the half year ending June 30, 2026, a decrease of -97.98%. This brings the company's revenue in the last twelve months to 77.00K. In the year 2025, Merchavia Holdings and Investments had annual revenue of 44.00K, down -63.03%.
Revenue (ttm)
77.00K
Revenue Growth
-63.03%
P/S Ratio
363.55
Revenue / Employee
77.00K
Employees
1
Market Cap
27.99M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.00K | -75.00K | -63.03% |
| Dec 31, 2024 | 119.00K | -1.73M | -93.56% |
| Dec 31, 2023 | 1.85M | -2.31M | -55.59% |
| Dec 31, 2022 | 4.16M | -6.45M | -60.78% |
| Dec 31, 2021 | 10.61M | 3.18M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.25B |
| Rafa Laboratories | 459.86M |
| BrainsWay | 180.82M |
| Identi Healthcare | 12.44M |
| Evogene | 4.94M |
| BioLineRx | 4.15M |
| Nextage Therapeutics | 2.51M |